About International Isotopes, Inc.

International Isotopes, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt tele therapy sources, as well as radioisotopes and radiochemical for medical research and clinical devices. It operates through the following segments: Radiochemical Products, Cobalt Products, Nuclear Medicine Standards, Radiological Services and Fluorine Products. The Radiochemical Products segment includes production and distribution of various isotopically pure radio chemicals for medical, industrial, or research applications. The Cobalt Products segment includes management of a cobalt irradiation contract, fabrication of cobalt capsules for tele therapy or irradiation devices, and recycling of expended cobalt sources. The Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. Radiological Services Segment concerns a wide array of miscellaneous services that consists of gemstone processing and field services that include source installation, removal, and radiation device decommissioning. The Fluorine Product segment involved the production of small scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. International Isotopes was founded in November 1995 and is headquartered in Idaho Falls, ID.

At the moment the company generates 9M USD in revenues.

On its last earning announcement, the company reported a loss of -0.01$ per share.

The book value per share is -0.01$

International Isotopes, Inc. website

Create a solid portfolio with INIS

Add INIS to your portfolio and optimize it!


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
9M 52.70% - -2.00% -1M -0.01 - - 416M -0.01 1M - 1M